141 related articles for article (PubMed ID: 2780050)
1. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.
Tonin PN; Yeger H; Stallings RL; Srinivasan PR; Lewis WH
Oncogene; 1989 Sep; 4(9):1117-21. PubMed ID: 2780050
[TBL] [Abstract][Full Text] [Related]
2. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
3. Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
Ask A; Persson L; Rehnholm A; Frostesjö L; Holm I; Heby O
Cancer Res; 1993 Nov; 53(21):5262-8. PubMed ID: 8221660
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal assignment of amplified genes in hydroxyurea-resistant hamster cells.
Tonin PN; Stallings RL; Carman MD; Bertino JR; Wright JA; Srinivasan PR; Lewis WH
Cytogenet Cell Genet; 1987; 45(2):102-8. PubMed ID: 3622008
[TBL] [Abstract][Full Text] [Related]
5. The gene for ornithine decarboxylase is co-amplified in hydroxyurea-resistant hamster cells.
Srinivasan PR; Tonin PN; Wensing EJ; Lewis WH
J Biol Chem; 1987 Sep; 262(26):12871-8. PubMed ID: 2887574
[TBL] [Abstract][Full Text] [Related]
6. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas.
Shiloh Y; Korf B; Kohl NE; Sakai K; Brodeur GM; Harris P; Kanda N; Seeger RC; Alt F; Latt SA
Cancer Res; 1986 Oct; 46(10):5297-301. PubMed ID: 3756879
[TBL] [Abstract][Full Text] [Related]
7. The gene for a novel protein, a member of the protein disulphide isomerase/form I phosphoinositide-specific phospholipase C family, is amplified in hydroxyurea-resistant cells.
Chaudhuri MM; Tonin PN; Lewis WH; Srinivasan PR
Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):645-50. PubMed ID: 1311171
[TBL] [Abstract][Full Text] [Related]
8. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract][Full Text] [Related]
9. Relationships between reversion of hydroxyurea resistance in hamster cells and the co-amplification of ribonucleotide reductase M2 component, ornithine decarboxylase and P5-8 genes.
McClarty GA; Tonin PN; Srinivasan PR; Wright JA
Biochem Biophys Res Commun; 1988 Aug; 154(3):975-81. PubMed ID: 3044371
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase M2 subunit sequences mapped to four different chromosomal sites in humans and mice: functional locus identified by its amplification in hydroxyurea-resistant cell lines.
Yang-Feng TL; Barton DE; Thelander L; Lewis WH; Srinivasan PR; Francke U
Genomics; 1987 Sep; 1(1):77-86. PubMed ID: 3311968
[TBL] [Abstract][Full Text] [Related]
11. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
[TBL] [Abstract][Full Text] [Related]
12. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
13. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
15. Expression of human chromosome 2 ornithine decarboxylase gene in ornithine decarboxylase-deficient Chinese hamster ovary cells.
Hsieh JT; Denning MF; Heidel SM; Verma AK
Cancer Res; 1990 Apr; 50(8):2239-44. PubMed ID: 2317811
[TBL] [Abstract][Full Text] [Related]
16. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.
Corvi R; Savelyeva L; Schwab M
Cancer Res; 1995 Aug; 55(16):3471-4. PubMed ID: 7627947
[TBL] [Abstract][Full Text] [Related]
17. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
19. Modification of myc gene amplification in human somatic cell hybrids.
Iman DS; Shay JW
Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
[TBL] [Abstract][Full Text] [Related]
20. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
Tonini GP; Verdona G; Garaventa A; Cornaglia-Ferraris P
Anticancer Res; 1987; 7(4B):729-32. PubMed ID: 3314672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
